癌症支持療法的全球市場 2023-2027年

癌症支持療法的市場規模在2022年～2027年間，預測將成長到65億6392萬美元，在預測期間內預計將以年複合成長率4.62％增長。

本報告提供癌症支持療法市場整體分析，提供市場規模與預測，趨勢，成長促進因素·課題，網羅了約25供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。市場成長的主要因素有癌症患者的增加，癌症治療伴隨的許多副作用，新興國家的未開發可能性。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模 2022
• 市場預測:2022-2027年的預測

第4章 市場規模實際成果

• 全球癌症sapotibukea市場2017～2021年
• 治療領域市場區隔分析2017-2021
• 流通管道市場區隔分析2017-2021
• 地區市場區隔分析2017-2021
• 國家市場區隔分析2017-2021

第5章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第6章 各治療領域的市場區隔

• 市場·市場區隔
• 各領域比較
• 化療貧血 - 市場規模與預測 2022-2027
• 化療嗜中性白血球低下症 - 市場規模與預測 2022-2027
• 癌症的疼痛 - 市場規模與預測 2022-2027
• CINV - 市場規模與預測 2022-2027
• 其他 - 市場規模與預測 2022-2027
• 各治療領域的市場機會

第7章 各流通管道市場區隔

• 市場·市場區隔
• 各流通管道比較
• 醫院的藥局 - 市場規模與預測 2022-2027
• 與藥妝店零售藥局 - 市場規模與預測 2022-2027
• 線上供應商 - 市場規模與預測 2022-2027
• 各流通管道的市場機會

第8章 客戶形勢

• 客戶形勢概要

第9章 各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美 - 市場規模與預測 2022-2027
• 歐洲 - 市場規模與預測 2022-2027
• 亞洲 - 市場規模與預測 2022-2027
• 其他地區(ROW) - 市場規模與預測 2022-2027
• 美國 - 市場規模與預測 2022-2027
• 英國 - 市場規模與預測 2022-2027
• 德國 - 市場規模與預測 2022-2027
• 中國 - 市場規模與預測 2022-2027
• 加拿大 - 市場規模與預測 2022-2027
• 各地區形勢的市場機會

第10章 促進因素，課題，及的趨勢

• 推動市場要素
• 市場課題
• 推動因素與課題的影響
• 市場趨勢

第11章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第12章 供應商分析

• 交易廠商
• 供應商的市場定位
• Amgen Inc.
• Baxter International Inc.
• Bayer AG
• Daiichi Sankyo Co. Ltd.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Heron Therapeutics Inc.
• Johnson and Johnson
• Kyowa Kirin Co. Ltd.
• Merck and Co. Inc.
• Novartis AG
• Purdue Pharma LP
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

第13章 附錄

Technavio has been monitoring the cancer supportive care market and is forecast to grow by $6,563.92 mn during 2022-2027, accelerating at a CAGR of 4.62% during the forecast period. Our report on the cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with the cancer treatment, and untapped potential in developing countries.

Technavio's cancer supportive care market is segmented as below:

By Distribution Channel

• Hospitals pharmacies
• Drug stores and retail pharmacies
• Online providers

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of biosimilars in cancer-associated treatment as one of the prime reasons driving the cancer supportive care market growth during the next few years. Also, outsourcing of biosimilars manufacturing activities and adoption of various strategies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cancer supportive care market covers the following areas:

• Cancer supportive care market sizing
• Cancer supportive care market forecast
• Cancer supportive care market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer supportive care market vendors that include Acacia Pharma Group Plc, Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson, Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the cancer supportive care market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapeutic Area
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global cancer supportive care market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global cancer supportive care market 2017 - 2021 ($ million)
• 4.2 Therapeutic area Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Therapeutic area Segment 2017 - 2021 ($ million)
• 4.3 Distribution channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapeutic Area

• 6.1 Market segments
• Exhibit 30: Chart on Therapeutic Area - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Therapeutic Area - Market share 2022-2027 (%)
• 6.2 Comparison by Therapeutic Area
• Exhibit 32: Chart on Comparison by Therapeutic Area
• Exhibit 33: Data Table on Comparison by Therapeutic Area
• 6.3 Chemotherapy-induced anemia - Market size and forecast 2022-2027
• Exhibit 34: Chart on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• 6.4 Chemotherapy-induced neutropenia - Market size and forecast 2022-2027
• Exhibit 38: Chart on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• 6.5 Cancer pain - Market size and forecast 2022-2027
• Exhibit 42: Chart on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Cancer pain - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Cancer pain - Year-over-year growth 2022-2027 (%)
• 6.6 CINV - Market size and forecast 2022-2027
• Exhibit 46: Chart on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on CINV - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on CINV - Year-over-year growth 2022-2027 (%)
• 6.7 Others - Market size and forecast 2022-2027
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.8 Market opportunity by Therapeutic Area
• Exhibit 54: Market opportunity by Therapeutic Area ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 57: Chart on Comparison by Distribution Channel
• Exhibit 58: Data Table on Comparison by Distribution Channel
• 7.3 Hospitals pharmacies - Market size and forecast 2022-2027
• Exhibit 59: Chart on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• 7.4 Drug stores and retail pharmacies - Market size and forecast 2022-2027
• Exhibit 63: Chart on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• 7.5 Online providers - Market size and forecast 2022-2027
• Exhibit 67: Chart on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Online providers - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Online providers - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 71: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 75: Chart on Geographic comparison
• Exhibit 76: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Canada - Market size and forecast 2022-2027
• Exhibit 109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 111: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 113: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 114: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 116: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 117: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 118: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 119: Matrix on vendor position and classification
• 12.3 Amgen Inc.
• Exhibit 120: Amgen Inc. - Overview
• Exhibit 121: Amgen Inc. - Product / Service
• Exhibit 122: Amgen Inc. - Key offerings
• 12.4 Baxter International Inc.
• Exhibit 123: Baxter International Inc. - Overview
• Exhibit 124: Baxter International Inc. - Business segments
• Exhibit 125: Baxter International Inc. - Key news
• Exhibit 126: Baxter International Inc. - Key offerings
• Exhibit 127: Baxter International Inc. - Segment focus
• 12.5 Bayer AG
• Exhibit 128: Bayer AG - Overview
• Exhibit 129: Bayer AG - Business segments
• Exhibit 130: Bayer AG - Key news
• Exhibit 131: Bayer AG - Key offerings
• Exhibit 132: Bayer AG - Segment focus
• 12.6 Daiichi Sankyo Co. Ltd.
• Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 134: Daiichi Sankyo Co. Ltd. - Business segments
• Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibit 137: Daiichi Sankyo Co. Ltd. - Segment focus
• 12.7 F. Hoffmann La Roche Ltd.
• Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 GlaxoSmithKline Plc
• Exhibit 143: GlaxoSmithKline Plc - Overview
• Exhibit 144: GlaxoSmithKline Plc - Business segments
• Exhibit 145: GlaxoSmithKline Plc - Key offerings
• Exhibit 146: GlaxoSmithKline Plc - Segment focus
• 12.9 Heron Therapeutics Inc.
• Exhibit 147: Heron Therapeutics Inc. - Overview
• Exhibit 148: Heron Therapeutics Inc. - Product / Service
• Exhibit 149: Heron Therapeutics Inc. - Key news
• Exhibit 150: Heron Therapeutics Inc. - Key offerings
• 12.10 Johnson and Johnson
• Exhibit 151: Johnson and Johnson - Overview
• Exhibit 152: Johnson and Johnson - Business segments
• Exhibit 153: Johnson and Johnson - Key news
• Exhibit 154: Johnson and Johnson - Key offerings
• Exhibit 155: Johnson and Johnson - Segment focus
• 12.11 Kyowa Kirin Co. Ltd.
• Exhibit 156: Kyowa Kirin Co. Ltd. - Overview
• Exhibit 157: Kyowa Kirin Co. Ltd. - Product / Service
• Exhibit 158: Kyowa Kirin Co. Ltd. - Key offerings
• 12.12 Merck and Co. Inc.
• Exhibit 159: Merck and Co. Inc. - Overview
• Exhibit 160: Merck and Co. Inc. - Business segments
• Exhibit 161: Merck and Co. Inc. - Key news
• Exhibit 162: Merck and Co. Inc. - Key offerings
• Exhibit 163: Merck and Co. Inc. - Segment focus
• 12.13 Novartis AG
• Exhibit 164: Novartis AG - Overview
• Exhibit 165: Novartis AG - Business segments
• Exhibit 166: Novartis AG - Key offerings
• Exhibit 167: Novartis AG - Segment focus
• 12.14 Purdue Pharma LP
• Exhibit 168: Purdue Pharma LP - Overview
• Exhibit 169: Purdue Pharma LP - Product / Service
• Exhibit 170: Purdue Pharma LP - Key offerings
• 12.15 Sanofi SA
• Exhibit 171: Sanofi SA - Overview
• Exhibit 172: Sanofi SA - Business segments
• Exhibit 173: Sanofi SA - Key news
• Exhibit 174: Sanofi SA - Key offerings
• Exhibit 175: Sanofi SA - Segment focus
• 12.16 Sun Pharmaceutical Industries Ltd.
• Exhibit 176: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 177: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 178: Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.17 Teva Pharmaceutical Industries Ltd.
• Exhibit 179: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 180: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 181: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 183: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 184: Inclusions checklist
• Exhibit 185: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 186: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 187: Research methodology
• Exhibit 188: Validation techniques employed for market sizing
• Exhibit 189: Information sources
• 13.5 List of abbreviations
• Exhibit 190: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global cancer supportive care market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Therapeutic area Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Therapeutic Area - Market share 2022-2027 (%)
• Exhibits31: Data Table on Therapeutic Area - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Therapeutic Area
• Exhibits33: Data Table on Comparison by Therapeutic Area
• Exhibits34: Chart on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Chemotherapy-induced anemia - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Chemotherapy-induced anemia - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Chemotherapy-induced neutropenia - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Chemotherapy-induced neutropenia - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Cancer pain - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Cancer pain - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Cancer pain - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on CINV - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on CINV - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on CINV - Year-over-year growth 2022-2027 (%)
• Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits54: Market opportunity by Therapeutic Area ($ million)
• Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits57: Chart on Comparison by Distribution Channel
• Exhibits58: Data Table on Comparison by Distribution Channel
• Exhibits59: Chart on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits60: Data Table on Hospitals pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Chart on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Hospitals pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on Drug stores and retail pharmacies - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on Drug stores and retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Online providers - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Online providers - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Online providers - Year-over-year growth 2022-2027 (%)
• Exhibits71: Market opportunity by Distribution Channel ($ million)
• Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits75: Chart on Geographic comparison
• Exhibits76: Data Table on Geographic comparison
• Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits109: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits110: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits111: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits112: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits113: Market opportunity By Geographical Landscape ($ million)
• Exhibits114: Impact of drivers and challenges in 2022 and 2027
• Exhibits115: Overview on Criticality of inputs and Factors of differentiation
• Exhibits116: Overview on factors of disruption
• Exhibits117: Impact of key risks on business
• Exhibits118: Vendors covered
• Exhibits119: Matrix on vendor position and classification
• Exhibits120: Amgen Inc. - Overview
• Exhibits121: Amgen Inc. - Product / Service
• Exhibits122: Amgen Inc. - Key offerings
• Exhibits123: Baxter International Inc. - Overview
• Exhibits124: Baxter International Inc. - Business segments
• Exhibits125: Baxter International Inc. - Key news
• Exhibits126: Baxter International Inc. - Key offerings
• Exhibits127: Baxter International Inc. - Segment focus
• Exhibits128: Bayer AG - Overview
• Exhibits129: Bayer AG - Business segments
• Exhibits130: Bayer AG - Key news
• Exhibits131: Bayer AG - Key offerings
• Exhibits132: Bayer AG - Segment focus
• Exhibits133: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits134: Daiichi Sankyo Co. Ltd. - Business segments
• Exhibits135: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits136: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits137: Daiichi Sankyo Co. Ltd. - Segment focus
• Exhibits138: F. Hoffmann La Roche Ltd. - Overview
• Exhibits139: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits140: F. Hoffmann La Roche Ltd. - Key news
• Exhibits141: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits142: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits143: GlaxoSmithKline Plc - Overview
• Exhibits144: GlaxoSmithKline Plc - Business segments
• Exhibits145: GlaxoSmithKline Plc - Key offerings
• Exhibits146: GlaxoSmithKline Plc - Segment focus
• Exhibits147: Heron Therapeutics Inc. - Overview
• Exhibits148: Heron Therapeutics Inc. - Product / Service
• Exhibits149: Heron Therapeutics Inc. - Key news
• Exhibits150: Heron Therapeutics Inc. - Key offerings
• Exhibits151: Johnson and Johnson - Overview
• Exhibits152: Johnson and Johnson - Business segments
• Exhibits153: Johnson and Johnson - Key news
• Exhibits154: Johnson and Johnson - Key offerings
• Exhibits155: Johnson and Johnson - Segment focus
• Exhibits156: Kyowa Kirin Co. Ltd. - Overview
• Exhibits157: Kyowa Kirin Co. Ltd. - Product / Service
• Exhibits158: Kyowa Kirin Co. Ltd. - Key offerings
• Exhibits159: Merck and Co. Inc. - Overview
• Exhibits160: Merck and Co. Inc. - Business segments
• Exhibits161: Merck and Co. Inc. - Key news
• Exhibits162: Merck and Co. Inc. - Key offerings
• Exhibits163: Merck and Co. Inc. - Segment focus
• Exhibits164: Novartis AG - Overview
• Exhibits165: Novartis AG - Business segments
• Exhibits166: Novartis AG - Key offerings
• Exhibits167: Novartis AG - Segment focus
• Exhibits168: Purdue Pharma LP - Overview
• Exhibits169: Purdue Pharma LP - Product / Service
• Exhibits170: Purdue Pharma LP - Key offerings
• Exhibits171: Sanofi SA - Overview
• Exhibits172: Sanofi SA - Business segments
• Exhibits173: Sanofi SA - Key news
• Exhibits174: Sanofi SA - Key offerings
• Exhibits175: Sanofi SA - Segment focus
• Exhibits176: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits177: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits178: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits179: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits180: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits181: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits182: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits183: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits184: Inclusions checklist
• Exhibits185: Exclusions checklist
• Exhibits186: Currency conversion rates for US$
• Exhibits187: Research methodology
• Exhibits188: Validation techniques employed for market sizing
• Exhibits189: Information sources
• Exhibits190: List of abbreviations